Pfizer to Seek US Approval For 3rd Covid-19 Vaccine Shot in Children
Pfizer and BioNTech announced the positive results from the clinical trial that were conducted on the safety and immune response of a third dose of the novel corona virus vaccine in the children between the age of 5 to 11 years and the companies also added that, they are soon going to be seeking the […]
Continue Reading